After a lifetime of weight struggles, Tiffany Howard, 40, who once was 317 lbs., says she is now a healthier role model for ...
Medifast® , the health and wellness company known for its science-backed, coach-guided lifestyle system OPTAVIA, premiered ...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions The latest update is out from Medifast ( (MED) ).
Many low-income Californians prescribed wildly popular weight loss drugs lost their coverage for the medications at the start ...
Low-income Californians who use GLP-1s for weight loss lost their coverage at the start of the new year, with officials advising diet and exercise instead.
The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug. The Wegovy pill, as it’s called, is first oral version of a GLP-1 drug that ...
Running for weight loss is as much of a mental journey as it is a physical one. Oftentimes, it’s a process that puts too much emphasis on the number on the scale, which can result in feelings of low ...
If you’re ready to change your life but don’t know where to begin, Running for Weight Loss offers a clear, supportive path forward. Guided by experts, you’ll learn how metabolism works, understand ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. When HCA Healthcare, one ...
Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The ...
Losing weight has officially become more convenient. The popular GLP-1 obesity treatment Wegovy is now available as a once-daily pill. On Monday evening, the Food and Drug Administration approved Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results